Beth Israel Deaconess Medical Center at CTAD 2026
Nov 16–19, 2026 Boston, MA ~1.7k attendees Website
Beth Israel Deaconess Medical Center takes part in 3 sessions at CTAD 2026 in Boston, its home city. Its program centres on cortical hyperexcitability in early Alzheimer's disease and how anti-amyloid treatment affects it. Its work includes a low-dose levetiracetam trial and digital phenotyping to detect subtle change.
| Organization | CTAD 2026 Attendance |
|---|---|
Beth Israel Deaconess Medical Center Boston, Massachusetts | |
Harvard teaching hospital whose Berenson-Allen Center studies brain stimulation and cortical excitability in Alzheimer's disease. | Poster Mon Nov 16 – Tue Nov 17 2:00pm Mon – 5:30pm Tue Poster Mon Nov 16 – Tue Nov 17 2:00pm Mon – 5:30pm Tue Poster Thu Nov 19 7:15am–5:00pm |
Instantly find 20 buyers from Beth Israel Deaconess Medical Center
Get a list of who you should contact, their contact info, and what to say.
Totally free and instant, no sign up necessary!
Not affiliated with or endorsed by the CTAD Conference. Organization details are derived from CTAD’s published program, poster list and sponsor page. Submit a correction